John ­McCamant

John ­McCamant, editor of Medical Technology Stock Letter, Berkeley, California. Its model portfolio returned an annualized 39% over five years, compared with 14% for the S&P 500 stock index. BioInvest.com

Investments that Are Worth the Risk for Higher Returns
Portfolio Strategy

Investments that Are Worth the Risk for Higher Returns

Michael Kass | June 10, 2019

As the bull market ages some investors are stretching their comfort zones to boost returns. Here are some great investments options to do that.